MAIN MOLECULAR TARGETS FOR PROSTATE CANCER THERAPY

MAIN MOLECULAR TARGETS FOR PROSTATE CANCER THERAPY

Androgenic pathway plays a pivotal role in the development of benign and malignant prostate tumors. Most of the prostate neoplasms are hormone-dependent at the time of diagnosis. Therapeutic interventions aimed at reducing the level of testosterone in the blood allow to stop progression of the disea...

Full description

Saved in:
Bibliographic Details
Main Authors: G. S. Krasnov, A. A. Dmitriev, N. N. Volchenko, T. V. Danilova, A. F. Sadritdinova, A. V. Snezhkina, N. V. Melnikova, M. S. Fedorova, V. A. Lakunina, A. A. Belova, B. Y. Alekseev, A. D. Kaprin, A. V. Kudryavtseva
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:Сибирский онкологический журнал
Subjects:
castrate resistant prostate cancer
androgen receptor
abiraterone
enzalutamide
mv3100
galeterone
vt-464
cyp17а1
Online Access:https://www.siboncoj.ru/jour/article/view/286
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.siboncoj.ru/jour/article/view/286

Similar Items